siRNA, Anti-TGDS, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT36983WQ-2OMe)

The product SIRGT36983WQ-2OMe is a type of small interfering RNA (siRNA) that targets TGDS gene and regulates the expression of gene. The siRNA interferes with the expression of TGDS gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001304430.1
Alternative Names CATMANS; SDR2E1; TDPGD
Related Diseases Catel-Manzke Syndrome
Purification HPLC
Target Gene
Gene ID 23483
Uniprot ID O95455
Sub Cat Target Species Modification Scale  
SIRGT37983WQ-2F TGDS Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT38983WQ-2MOE TGDS Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT39983WQ-LNA TGDS Human Locked Nucleic Acid (LNA) Inquiry
SIRGT36983WQ-RB TGDS Human Ribo-modified Inquiry
SIRGT37983WQ-BB TGDS Human Backbone-modified Inquiry

Related Products